Related Experiment Videos
Update on the management of status asthmaticus
Insights
This study reviews current treatments for severe childhood asthma attacks (status asthmaticus). Key therapies include oxygen, inhaled medications, and corticosteroids, with other options for critical cases.
Area of Science:
- Pediatrics
- Pulmonology
- Emergency Medicine
Background:
- Asthma is a prevalent and severe condition in children, leading to significant healthcare costs and mortality.
- Status asthmaticus, a severe asthma exacerbation, requires prompt and effective therapeutic interventions.
Purpose of the Study:
- To examine current therapeutic strategies for managing status asthmaticus in pediatric patients.
- To review the evidence supporting various treatment modalities for severe asthma exacerbations.
Main Methods:
- Literature review of recent trends in the management of status asthmaticus.
- Analysis of the efficacy and indications for different pharmacological and non-pharmacological interventions.
Main Results:
- Oxygen, inhaled beta-adrenergic agonists, and corticosteroids are primary treatments.
- Ipratropium bromide aids bronchodilation in non-responders; theophylline's role in acute therapy is inconclusive.
- Antibiotics are reserved for infections; magnesium sulfate and heliox may benefit critically ill children.
- Mechanical ventilation carries risks, with permissive hypercapnia potentially reducing barotrauma.
Conclusions:
- Standard therapy for status asthmaticus involves oxygen, inhaled beta-agonists, and corticosteroids.
- Adjunctive therapies like ipratropium bromide, magnesium sulfate, and heliox have specific roles.
- Preventive measures include allergen/tobacco avoidance, corticosteroid use, and adherence to treatment.
Abstract:
Asthma is a common and debilitating problem in children. Its many costs to society include morbidity, hospitalization and treatment expenses, and a rising mortality rate. This paper examines recent trends in therapy for status asthmaticus. Oxygen, inhaled beta-adrenergic agonists, and corticosteroids remain the cornerstones of therapy for the child with a severe exacerbation of asthma. Ipratropium bromide provides additional bronchodilatation in the patient who does not respond to standard therapy. Theophylline may have a role in chronic outpatient management of asthma, but the data supporting the addition of this medication in acute therapy for status asthmaticus are inconclusive. Antibiotics are only indicated in children with asthma complicated by infection, such as sinusitis or pneumonia. Magnesium sulfate and heliox may have a role in helping the asthmatic child who is critically ill and for whom other interventions have failed. Mechanical ventilation has many complications. The concept of permissive hypercapnia may be important in limiting barotrauma. Prevention of exacerbations of asthma include limiting environmental exposure to allergens and tobacco, using corticosteroids, and reinforcing compliance with therapy.